An efficient two-stage method has been developed for the synthesis of perhalogenated monohydroxy derivatives of the closo-decaborate anion with the composition 2-B10X9OH2– (X = Cl, Br). The method involves complete halogenation of the boron cage in the initial DMF-containing derivative 2‑B10H9OCHNMe2– by its reaction with sulfuryl chloride (SO2Cl2) or elemental bromine (Br2), followed by hydrolysis of the obtained perhalogenated derivatives 2-B10X9OCHNMe2– (X = Cl, Br) with hydrazine monohydrate (N2H4·H2O). This synthetic approach allows for the production of the target compounds with high yield (80–85%) and high purity, as confirmed by a range of physicochemical analysis methods, including multinuclear 11B, 1H, and 13C NMR spectroscopy, IR spectroscopy, and elemental analysis. The structures of the 2-B10X9OCHNMe2– and 2-B10X9OH2– anions were determined by single-crystal X-ray diffraction analysis.
Golubev et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: